Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares RMEAX

Morningstar Medalist Rating
  • NAV / 1-Day Return $18.15  /  −0.77 %
  • Fund Size $1.5B
  • Adjusted Expense Ratio 0.950%
  • Net Expense Ratio 0.290%
  • Fee Level: Distribution Average
  • Share Class Type No Load
  • Morningstar Category Global Large-Stock Blend
  • Equity Style Box (Funds) Large Blend
  • Minimum Initial Investment $0
  • Investment Status Open
  • TTM Yield 1.40%
  • Turnover Ratio 21%

Morningstar’s Analysis RMEAX

Will RMEAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Aspiriant Risk-Managed Equity Allc Adv holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RMEAX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 73.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

GMO Quality VI

33.79 493M
—

Schwab Fundamental Emerging MarketsEqETF

7.34 107M
—

RIEF STRATEGIC PARTNERS FUND

6.96 102M
—

Baillie Gifford Emerging Markets Eqs K

5.23 76M
—

GMO Equity Dislocation Invmt A USD Acc

4.51 66M
—

AQR Large Cap Defensive Style R6

3.83 56M
—

iShares MSCI ACWI ETF

3.35 49M
—

iShares MSCI Global Min Vol Factor ETF

3.33 49M
—

Viking Global Equities Lp

3.33 49M
—

JPMorgan Prime Money Market Inst

3.15 46M
Cash and Equivalents

Sponsor Center